SAB Biotherapeutics Inc (SABSW) earnings · $860.0K cap
These earnings events as JSON? API free 100/daySAB Biotherapeutics Inc (SABSW) warrant listed on NASDAQ.
This SABSW earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SABSW revenue for 2025-12-31 was $0. Net income was $13.3M. Revenue was down 100.0% from 2023-12-31 to 2025-12-31. SABSW currently screens at market cap $860.0K.
When the next SABSW 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2023-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SABSW research stays on the stock page; the tape stays on the quote page.
SABSW earnings FAQ
What is SABSW's latest net income?
Latest cached SAB Biotherapeutics Inc (SABSW) net income was $13.3M. Statements: https://lician.com/financials/sabsw
What period does the latest SABSW earnings print cover?
The latest cached SAB Biotherapeutics Inc (SABSW) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2023.
Where are SABSW earnings listed?
Cached earnings facts for SAB Biotherapeutics Inc (SABSW) are listed at https://lician.com/earnings/sabsw. Statements: https://lician.com/financials/sabsw
Not investment advice.